Long-term Study Of Ropinirole In Restless Legs Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

404

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Restless Legs Syndrome
Interventions
DRUG

Placebo

Matching Placebo

DRUG

Ropinirole

Ropinirole IR 0.25mg/day to 4mg/day for RLS

Trial Locations (39)

2050

GSK Investigational Site, Camperdown

2317

GSK Investigational Site, Hamar

3002

GSK Investigational Site, East Melbourne

3010

GSK Investigational Site, Bern

3168

GSK Investigational Site, Clayton

4021

GSK Investigational Site, Kippa-Ring

5000

GSK Investigational Site, Odense C

5011

GSK Investigational Site, Woodville

7100

GSK Investigational Site, Vejle

8091

GSK Investigational Site, Zurich

9000

GSK Investigational Site, Aalborg

10787

GSK Investigational Site, Berlin

10969

GSK Investigational Site, Berlin

19053

GSK Investigational Site, Schwerin

20014

GSK Investigational Site, San Sebastián

26655

GSK Investigational Site, Westerstede

27100

GSK Investigational Site, Pavia

28036

GSK Investigational Site, Madrid

35039

GSK Investigational Site, Marburg

40123

GSK Investigational Site, Bologna

80331

GSK Investigational Site, Munich

93053

GSK Investigational Site, Regensburg

96047

GSK Investigational Site, Bamberg

775 20

GSK Investigational Site, Olomouc

702 00

GSK Investigational Site, Ostrava

535 03

GSK Investigational Site, Pardubice

120 00

GSK Investigational Site, Prague

00163

GSK Investigational Site, Rome

3000-075

GSK Investigational Site, Coimbra

1649-035

GSK Investigational Site, Lisbon

831 03

GSK Investigational Site, Bratislava

833 05

GSK Investigational Site, Bratislava

018 41

GSK Investigational Site, Dubnica nad Váhom

054 01

GSK Investigational Site, Levoča

010 01

GSK Investigational Site, Žilina

08017

GSK Investigational Site, Barcelona

SE-774 82

GSK Investigational Site, Avesta

SE-412 55

GSK Investigational Site, Gothenburg

701 85

GSK Investigational Site, Örebro

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY